Embecta Corp.
NASDAQ:EMBCDrug Manufacturers - Specialty & Generic
+$0.02 today
- Market cap
- $345.06M
- Beta
- 0.81
- P/E (TTM)
- 1.6
- EPS (TTM)
- $1.92
- Dividend yield
- 14.79%
Volume 0.72M
Average 1.95M
EMBC Common Stock
The par or stated value of issued common shares, plus paid-in capital where reported together.
Embecta Corp.NASDAQ: EMBC
Common Stock · Q2 FY2026 · quarter ended Mar 2026
Common stock broadly unchanged from a year ago
Common stock stood at $600K at the end of Q2 FY2026, up 0.0% from a year earlier and up 0.0% from the prior quarter. Over 3 fiscal years it compounded at +0.0% a year.
Context
- Common stock amounted to 0.1% of total assets at the end of Q2 FY2026, unchanged from a year earlier.
- Common stock increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether common stock keeps rising in the next quarterly balance sheet after a +0.0% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Common Stock history
USD · from the balance sheet
- Latest · FY2025
- 600K USD
- Year-over-year change
- +0.0%
- 4-year CAGR
- -83.8%
| Period | Period end | Common Stock | YoY change |
|---|---|---|---|
| FY2025 | 2025-09-30 | 600K | +0.0% |
| FY2024 | 2024-09-30 | 600K | +0.0% |
| FY2023 | 2023-09-30 | 600K | +0.0% |
| FY2022 | 2022-09-30 | 600K | -99.9% |
| FY2021 | 2021-09-30 | 865M | — |
Common Stock vs competitors
How EMBC compares with its peers on the latest reported figures
- EMBC's Mar 2026 common stock of $600K is the 4th highest of the 11 companies compared; the peer median is $75.5K.
- Its year-over-year change of +0.0% is the 7th highest of 11, against a peer median of +0.7%.
- Common stock amounts to 0.1% of total assets for EMBC, versus a peer median of 0.0%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $2.6M | +1.7% | +0.1% | 0.4% | |
| Mar 2026 | $1.19M | +0.9% | +5.0% | 0.1% | |
| Mar 2026 | $900K | +0.0% | +4.0% | 0.1% | |
| Mar 2026 | $600K | +0.0% | +0.0% | 0.1% | |
| Mar 2026 | $124K | +25.3% | +30.4% | 0.1% | |
| Mar 2026 | $100K | +0.0% | +0.0% | 0.0% | |
| Jun 2026 | $51K | -3.8% | -1.3% | 0.0% | |
| Mar 2026 | $16K | +14.3% | +2.5% | 0.0% | |
| Mar 2026 | $10K | +11.1% | +26.0% | 0.0% | |
| Mar 2026 | $7.17K | +0.4% | -0.5% | 0.0% | |
| Mar 2026 | $2K | +0.0% | +0.0% | 0.0% | |
| Peer median (excluding EMBC) | $75.5K | +0.7% | +1.3% | 0.0% | |
Competitors are the stored peer set for EMBC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Sep 2021 | FY2022 Sep 2022 | FY2023 Sep 2023 | FY2024 Sep 2024 | FY2025 Sep 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 0 | 330.9M | 326.3M | 267.5M | 225.5M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 150.6M | 23.4M | 17.9M | 248M | 148.9M |
| Inventory | 118M | 122.8M | 152.1M | 171.5M | 178.6M |
| Other Current Assets | 200K | 109.7M | 142.4M | 74M | 3.1M |
| Total Current Assets | 292M | 664.7M | 749.1M | 761M | 631.4M |
| Property, Plant & Equipment (Net) | 451M | 301.6M | 323.2M | 290.4M | 48.5M |
| Goodwill | 16M | 15.7M | 15.6M | 15.6M | 15.4M |
| Intangible Assets | 18M | 8.9M | 9.1M | 8.1M | 7M |
| Long-term Investments | (11.4M) | (95.5M) | 0 | 0 | 0 |
| Tax Assets | 11.4M | 95.5M | 0 | 0 | 20.2M |
| Other Non-current Assets | 11M | 95.5M | 117.4M | 210.2M | 368.4M |
| Total Non-current Assets | 496M | 421.7M | 465.3M | 524.3M | 459.5M |
| Total Assets | 788M | 1.09B | 1.21B | 1.29B | 1.09B |
| Account Payables | 54.2M | 41.4M | 53.5M | 91M | 74.2M |
| Short-term Debt | 1M | 9.5M | 9.5M | 9.5M | 12.9M |
| Tax Payables | 0 | 27.2M | 33.6M | 26.7M | 0 |
| Deferred Revenue | 0 | 0 | 33.6M | 0 | 0 |
| Other Current Liabilities | 0 | 198M | 33.6M | 0 | 115.2M |
| Total Current Liabilities | 164M | 301M | 353.5M | 374M | 261.5M |
| Long-term Debt | 0 | 1.6B | 1.59B | 1.57B | 1.39B |
| Deferred Tax Liabilities | 0 | 46.1M | 0 | 11.9M | 62.6M |
| Deferred Revenue (Non-current) | 0 | (46.1M) | 0 | 0 | 0 |
| Other Non-current Liabilities | 26.7M | 41.8M | 57.2M | 42.2M | 63.2M |
| Total Non-current Liabilities | 29.7M | 1.68B | 1.68B | 1.65B | 1.48B |
| Total Liabilities | 194M | 1.98B | 2.04B | 2.02B | 1.74B |
| Common Stock | 865M | 600K | 600K | 600K | 600K |
| Retained Earnings | 0 | (577.1M) | (541.1M) | (498.6M) | (445.6M) |
| Accumulated OCI | (271M) | (324.9M) | (309.1M) | (292.8M) | (285.6M) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 594M | (891.4M) | (821.7M) | (738.3M) | (650.6M) |
| Total Debt | 4.1M | 1.64B | 1.64B | 1.61B | 1.43B |
| Net Debt | 4.1M | 1.31B | 1.31B | 1.34B | 1.2B |
Embecta Corp.
NASDAQ:EMBC
Intrinsic Alpha fair value
Locked
Current Price
$6.09
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.